Product Information
LAMOTRIGINE ODT 200 MG TABLET is a generic product labeled by Endo USA Inc., priced at $1.6434 per EA under NDC 49884048711. Its NADAC has been published 498 times since Mar 22, 2017.
FDA first approved this application on Oct 27, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Lamotrigine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
200 mg/1
Manufacturer
Endo USA Inc.NDC
49884048711
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LAMOTRIGINEApproval Type
Generic (ANDA)
FDA Application
ANDA204158FDA Approved
10/27/2015
TE Code
AB
On Market Since
12/16/2015
Pharmacological Classes
Price Statistics
The NADAC for LAMOTRIGINE ODT 200 MG TABLET has been published 498 times since Mar 22, 2017, and over the history we have for it it has declined 75.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.6434 per EA |
|---|---|
| All-time high | $8.2101 (Jan 10, 2018) |
| All-time low | $1.3404 (Jul 22, 2026) |
| 52-week high | $2.5906 |
| 52-week low | $1.3404 |
| Median price | $5.2232 |
| Average price | $4.8810 |
| Largest weekly change | +92.9% (Nov 22, 2023) |
| Weeks tracked | 498 |
| Tracking since | Mar 22, 2017 |
Generic Alternatives
The matcher finds 15 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 95% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Endo USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lamotrigine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anti-epileptic Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LAMOTRIGINE ODT 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LAMOTRIGINE ODT 200 MG TABLET, manufactured by Endo USA Inc., is $1.6434 per EA (NDC 49884048711), effective Sep 30, 2026.
How has the price of LAMOTRIGINE ODT 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for LAMOTRIGINE ODT 200 MG TABLET has declined 75.6%. It has been tracked across 498 weekly CMS publications since Mar 22, 2017.
What are the highest and lowest recorded NADAC prices for LAMOTRIGINE ODT 200 MG TABLET?
Since Mar 22, 2017, the NADAC for LAMOTRIGINE ODT 200 MG TABLET has ranged from a low of $1.3404 (Jul 22, 2026) to a high of $8.2101 (Jan 10, 2018), with a median of $5.2232 per EA.
Are there cheaper alternatives to LAMOTRIGINE ODT 200 MG TABLET?
Yes. 15 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LAMOTRIGINE 200 MG TABLET, is $0.0825 per EA — about 95% below LAMOTRIGINE ODT 200 MG TABLET.
Who manufactures LAMOTRIGINE ODT 200 MG TABLET?
LAMOTRIGINE ODT 200 MG TABLET (NDC 49884048711) is labeled by Endo USA Inc., and CMS classifies it as a generic product.